ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?

• M. Garnier,
• D. Blez

Affiliations

M. Garnier

Corresponding author.; Sorbonne University, GRC29, APHP.6, DMU DREAM, Anesthesiology and Critical Care Medicine Department, Paris, France

D. Blez

Sorbonne University, GRC29, APHP.6, DMU DREAM, Anesthesiology and Critical Care Medicine Department, Paris, France